On the stock market since 1996, it operates in the world of health and science. It has 201 employees. Now — the numbers.
This is an established company with proven profits.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
Average growth of 36% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $43.2M would still be left in the vault — a solid cushion for hard times.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
The net profit margin is 25% — still a thick cushion, though costs have been eating into it lately.
Over the last 3 years, sales grew about 43% a year on average.
There is $67.2M in the vault; even if every debt were paid off, $43.2M would remain.
The price action doesn’t yet back an upward turn.
On our five-subject report card, ATRS sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: ATRS is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.